2784590-83-4
Chemical Structure
Gimaglipron
Synonym(s): GLP-1 receptor agonist 11
- CAS No.: 2784590-83-4
- Formula:C31H31ClFN3O4
- Molecular Weight:564.05
InChIKey: BWGRQMSFZQCDNS-DEOSSOPVSA-N
SMILES: FC(C=C(C=C1)Cl)=C1COC(C=CC=C2)=C2C(CC3)CCN3CC(N(C4=C5)C[C@@H]6CCO6)=NC4=CC=C5C(O)=O
Biological Activity: GLP-1 receptor agonist 11 is a GLP-1 receptor agonist[1].GLP-1 receptor agonist 11 activates the GLP-1 receptor[1].GLP-1 receptor agonist 11 can be used for the research of diabetes, non-alcoholic fatty liver disease, glucose intolerance, dyslipidemia, syndrome x, arteriosclerosis, hypertension, obesity, hepatic fibrosis, cirrhosis, somnolence, hyperglycemia, hyperlipidemia, atherosclerosis, hypertriglyceridemia, type 1 diabetes, type 2 diabetes, diabetic dyslipidemia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Gimaglipron | 99.25% | GLP-1 receptor agonist 11 is a GLP-1 receptor agonist.GLP-1 receptor agonist 11 activates the GLP-1 receptor.GLP-1 receptor agonist 11 can be used for the research of diabetes, non-alcoholic fatty liver disease, glucose intolerance, dyslipidemia, syndrome x, arteriosclerosis, hypertension, obesity, hepatic fibrosis, cirrhosis, somnolence, hyperglycemia, hyperlipidemia, atherosclerosis, hypertriglyceridemia, type 1 diabetes, type 2 diabetes, diabetic dyslipidemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
